MedPath

陕西博森生物制药股份集团有限公司

Ownership
-
Established
2002-12-12
Employees
-
Market Cap
-
Website
www.chinabosen.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

135

NMPA:135

Drug Approvals

Voriconazole for Injection

Product Name
注射用伏立康唑
Approval Number
国药准字H20249610
Approval Date
Dec 1, 2024
NMPA

Peramivir Injection

Product Name
帕拉米韦注射液
Approval Number
国药准字H20249216
Approval Date
Oct 29, 2024
NMPA

Doxofylline Injection

Product Name
多索茶碱注射液
Approval Number
国药准字H20244561
Approval Date
Jul 30, 2024
NMPA

Doxofylline Injection

Product Name
多索茶碱注射液
Approval Number
国药准字H20244562
Approval Date
Jul 30, 2024
NMPA

Ropivacaine Hydrochloride Injection

Product Name
盐酸罗哌卡因注射液
Approval Number
国药准字H20244602
Approval Date
Jul 30, 2024
NMPA

Ropivacaine Hydrochloride Injection

Product Name
盐酸罗哌卡因注射液
Approval Number
国药准字H20244603
Approval Date
Jul 30, 2024
NMPA

Ropivacaine Hydrochloride Injection

Product Name
盐酸罗哌卡因注射液
Approval Number
国药准字H20244604
Approval Date
Jul 30, 2024
NMPA

Ropivacaine Hydrochloride Injection

Product Name
盐酸罗哌卡因注射液
Approval Number
国药准字H20244605
Approval Date
Jul 30, 2024
NMPA

Diquafosol Sodium Eye Drops

Product Name
地夸磷索钠滴眼液
Approval Number
国药准字H20244361
Approval Date
Jun 28, 2024
NMPA

Ambroxol Hydrochloride Oral Solution

Product Name
盐酸氨溴索口服溶液
Approval Number
国药准字H20244122
Approval Date
Jun 25, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 14
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.